2003
DOI: 10.1046/j.1365-2265.2003.18021.x
|View full text |Cite
|
Sign up to set email alerts
|

Letters to the Editors: 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
11
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(12 citation statements)
references
References 3 publications
1
11
0
Order By: Relevance
“…Oral corticosteroid therapy has been well correlated with CS, and most physicians are aware of the dangers, having always to balance the cost–effect ratio 2. According to accumulated data, topical, aerosol, inhaled, and injectable corticosteroid therapy may also have adverse effects, including CS 2,812. There have been several cases of children who received intralesional injections into keloid scars or other wounds (such as burns) and developed CS that persisted for a long time (up to 9 months) 13.…”
Section: Introductionmentioning
confidence: 99%
“…Oral corticosteroid therapy has been well correlated with CS, and most physicians are aware of the dangers, having always to balance the cost–effect ratio 2. According to accumulated data, topical, aerosol, inhaled, and injectable corticosteroid therapy may also have adverse effects, including CS 2,812. There have been several cases of children who received intralesional injections into keloid scars or other wounds (such as burns) and developed CS that persisted for a long time (up to 9 months) 13.…”
Section: Introductionmentioning
confidence: 99%
“…It is also very rare in infancy. However, topical application of potent corticosteroids can cause Cushing’s syndrome, as well as suppression of the hypothalamic-pituitary-adrenal axis [4,5,6,7]. Sufficient exogenous glucocorticoids can be absorbed through the skin and can result in Cushing’s syndrome.…”
Section: Introductionmentioning
confidence: 99%
“…Sufficient exogenous glucocorticoids can be absorbed through the skin and can result in Cushing’s syndrome. Clobetasol propionate (0.05%) is the most potent topical corticosteroid available and there are reports of adrenal suppression due to its prolonged use [4,5,6]. …”
Section: Introductionmentioning
confidence: 99%
“…Iatrogenic Cushing's syndrome has also been reported in a few patients treated with inhaled glucocorticoids and drugs such as itraconazole and clarithromycin, which inhibit hepatic cytochrome P450 3A (CYP3A), thus increasing glucocorticoid bioavailability [4][5][6]. Continuous cutaneous application of glucocorticoid preparations (e.g., ointments) on injured skin may also cause the development of iatrogenic Cushing's syndrome [7][8][9]. In the abovementioned circumstances, measurement of serum and urinary cortisol will yield variably increased levels in patients administered cortisone, hydrocortisone, prednisone and prednisolone as these drugs cross-react in most cortisol assays.…”
Section: Synthetic Glucocorticoidsmentioning
confidence: 98%